EP3355877A4 - Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci - Google Patents
Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci Download PDFInfo
- Publication number
- EP3355877A4 EP3355877A4 EP16852276.1A EP16852276A EP3355877A4 EP 3355877 A4 EP3355877 A4 EP 3355877A4 EP 16852276 A EP16852276 A EP 16852276A EP 3355877 A4 EP3355877 A4 EP 3355877A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- miction
- frequency
- reducing
- manufacturing
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/870,676 US10596127B2 (en) | 2013-03-14 | 2015-09-30 | Composition for reducing the frequency of urination, method of making and use thereof |
| PCT/US2016/049246 WO2017058436A1 (fr) | 2015-09-30 | 2016-08-29 | Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3355877A1 EP3355877A1 (fr) | 2018-08-08 |
| EP3355877A4 true EP3355877A4 (fr) | 2019-05-15 |
Family
ID=58424324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP16852276.1A Withdrawn EP3355877A4 (fr) | 2015-09-30 | 2016-08-29 | Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3355877A4 (fr) |
| JP (1) | JP2018529710A (fr) |
| KR (1) | KR20180066113A (fr) |
| CN (1) | CN108430465A (fr) |
| AU (1) | AU2016331879A1 (fr) |
| SG (1) | SG11201805527QA (fr) |
| WO (1) | WO2017058436A1 (fr) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9119878B2 (en) * | 2010-07-08 | 2015-09-01 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5395626A (en) * | 1994-03-23 | 1995-03-07 | Ortho Pharmaceutical Corporation | Multilayered controlled release pharmaceutical dosage form |
| WO1999059552A1 (fr) * | 1998-05-15 | 1999-11-25 | Chugai Seiyaku Kabushiki Kaisha | Preparations a liberation controlee |
| US20030194429A1 (en) * | 2002-04-10 | 2003-10-16 | Miller Frederick H. | Multi-phase, multi-compartment capsular delivery apparatus for therapeutic compositions and methods for using same |
| MXPA04010408A (es) * | 2002-04-24 | 2005-02-17 | Boehringer Ingelheim Pharma | Combinacion farmaceutica para el tratamiento de hiperplasia prostatica benigna o para la prevencion a largo plazo de la retencion urinaria aguda. |
| US20080095843A1 (en) * | 2006-07-11 | 2008-04-24 | Nutalapati Siva R K | Controlled-release formulations |
| TWI609702B (zh) * | 2006-11-09 | 2018-01-01 | 歐瑞根治療有限公司 | 層狀醫藥調配物 |
| CN107569690A (zh) * | 2012-01-04 | 2018-01-12 | 韦尔斯利医药有限公司 | 用于缓解尿频的延长释放制剂及其使用方法 |
| MY173582A (en) * | 2012-01-04 | 2020-02-04 | Wellesley Pharmaceuticals Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| CN103191430A (zh) * | 2012-01-04 | 2013-07-10 | 韦尔斯利医药有限公司 | 用于缓解尿频的缓释制剂及其使用方法 |
| CN107157991A (zh) * | 2012-03-19 | 2017-09-15 | 韦尔斯利医药有限公司 | 用于缓解尿频的延长释放制剂及其使用方法 |
| CN107335057A (zh) * | 2012-07-27 | 2017-11-10 | 韦尔斯利医药有限公司 | 用于缓解尿频的药物制剂及其使用方法 |
| TW201422254A (zh) * | 2012-11-21 | 2014-06-16 | Ferring Bv | 用於速釋及延釋的組成物 |
| BR102013020508B1 (pt) * | 2013-08-12 | 2021-01-12 | Ems S/A. | Forma de dosagem que compreende um inibidor de esteroide 5-alfa-redutase e um bloqueador alfa, processo para a preparaçãode uma forma de dosagem e uso da forma de dosagem |
-
2016
- 2016-08-29 EP EP16852276.1A patent/EP3355877A4/fr not_active Withdrawn
- 2016-08-29 SG SG11201805527QA patent/SG11201805527QA/en unknown
- 2016-08-29 KR KR1020187011990A patent/KR20180066113A/ko not_active Withdrawn
- 2016-08-29 WO PCT/US2016/049246 patent/WO2017058436A1/fr not_active Ceased
- 2016-08-29 CN CN201680069818.6A patent/CN108430465A/zh active Pending
- 2016-08-29 AU AU2016331879A patent/AU2016331879A1/en not_active Abandoned
- 2016-08-29 JP JP2018516063A patent/JP2018529710A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9119878B2 (en) * | 2010-07-08 | 2015-09-01 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108430465A (zh) | 2018-08-21 |
| JP2018529710A (ja) | 2018-10-11 |
| WO2017058436A1 (fr) | 2017-04-06 |
| EP3355877A1 (fr) | 2018-08-08 |
| SG11201805527QA (en) | 2018-07-30 |
| KR20180066113A (ko) | 2018-06-18 |
| AU2016331879A1 (en) | 2018-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3402815A4 (fr) | Utilisation de mutants endo-s2 comme glycosynthases, procédé de fabrication et d'utilisation pour la glycoingénierie de glycoprotéines | |
| EP3460021A4 (fr) | Agent d'hydrofugation, et procédé de fabrication de celui-ci | |
| MA43802A (fr) | Matières cellulosiques et procédés de fabrication et d'utilisation de celles-ci | |
| EP3395715A4 (fr) | Récipient d'aliment et procédé de fabrication de celui-ci | |
| EP3386550A4 (fr) | Procédés et compositions pour la fabrication et l'utilisation d'acides nucléiques de guidage | |
| EP3540001A4 (fr) | Résine hautement absorbante et procédé pour sa production | |
| EP2865647A4 (fr) | Matière active d'anode et procédé pour la fabrication de celle-ci | |
| EP3467135A4 (fr) | Tôle d'acier mince, et procédé de fabrication de celle-ci | |
| EP3378897A4 (fr) | Composition de résine époxy, procédé pour sa production et utilisation de la composition | |
| EP3425016A4 (fr) | Composition pour polissage, et procédé de polissage mettant en ouvre celle-ci | |
| MA46791A (fr) | Composés et procédés pour réduire l'expression d'atxn3 | |
| EP3581618C0 (fr) | Composition de caoutchouc, et procédé de fabrication de celle-ci | |
| EP3455895A4 (fr) | Compositions et procédés pour la fabrication d'électrode | |
| MA42055A (fr) | Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ci | |
| EP3381498A4 (fr) | Microaiguille et procédé pour la produire | |
| EP3320998A4 (fr) | Procédé pour la fabrication d'unité de palier à roulement | |
| EP3337864A4 (fr) | Composition de revêtement pelable et procédé de fabrication de cette dernière | |
| EP3713537A4 (fr) | Compositions topiques, leur procédé de fabrication et leur procédé d'utilisation | |
| EP3480258A4 (fr) | Composition mao sous forme solide comprenant un al203, et procédé de fabrication de celle-ci | |
| EP3373910A4 (fr) | Formulation d'échinomycine, procédé de fabrication et méthode d'utilisation de cette dernière | |
| EP2827851A4 (fr) | Formulation à libération prolongée pour réduire la fréquence de la miction et procédé d'utilisation de celle-ci | |
| EP3347446A4 (fr) | Composition stable de blanchisserie ou de nettoyage, procédé pour la préparer, et procédé d'utilisation | |
| EP3711741A4 (fr) | Procédé de fabrication de complexe pour greffe osseuse et complexe pour greffe osseuse fabriqué selon le procédé | |
| EP3778961A4 (fr) | Rail, et procédé de fabrication de celui-ci | |
| EP3517296A4 (fr) | Film antiadhésif et procédé pour la fabrication de celui-ci |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20180424 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20190412 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/58 20060101ALI20190408BHEP Ipc: A61K 9/50 20060101ALI20190408BHEP Ipc: A61P 7/12 20060101ALI20190408BHEP Ipc: A61P 7/00 20060101ALI20190408BHEP Ipc: A61K 45/06 20060101ALI20190408BHEP Ipc: A61K 31/19 20060101AFI20190408BHEP Ipc: A61K 9/00 20060101ALI20190408BHEP Ipc: A61K 31/167 20060101ALI20190408BHEP Ipc: A61K 31/18 20060101ALI20190408BHEP Ipc: A61K 31/192 20060101ALI20190408BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20191112 |